These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12552085)

  • 1. Uptake and antifungal activity of oligonucleotides in Candida albicans.
    Disney MD; Haidaris CG; Turner DH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1530-4. PubMed ID: 12552085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to targeting RNA with oligonucleotides: inhibition of group I intron self-splicing.
    Disney MD; Childs JL; Turner DH
    Biopolymers; 2004 Jan; 73(1):151-61. PubMed ID: 14691946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activity of a Candida albicans GGTase I inhibitor-alanine conjugate. Inhibition of Rho1p prenylation in C. albicans.
    Murthi KK; Smith SE; Kluge AF; Bergnes G; Bureau P; Berlin V
    Bioorg Med Chem Lett; 2003 Jun; 13(11):1935-7. PubMed ID: 12749902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Terric acid on the growth, cellular morphology and macromolecular synthesis of C. albicans].
    Li SB; Wang J; Zhong YC
    Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):447-51. PubMed ID: 17672303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of T-2307, a novel arylamidine, in Candida albicans.
    Nishikawa H; Yamada E; Shibata T; Uchihashi S; Fan H; Hayakawa H; Nomura N; Mitsuyama J
    J Antimicrob Chemother; 2010 Aug; 65(8):1681-7. PubMed ID: 20513704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of amigluracil and levorin on membrane permeability and protein synthesis in Candida albicans protoplasts].
    Obukhovskaia AS; Lishnevskaia EB; Tereshin IM
    Antibiotiki; 1978 Apr; 23(4):345-8. PubMed ID: 348091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal Activity of Mammalian Serum Amyloid A1 against
    Gong J; Wu J; Ikeh M; Tao L; Zhang Y; Bing J; Nobile CJ; Huang G
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Candida albicans growth by brominated furanones.
    Duo M; Zhang M; Luk YY; Ren D
    Appl Microbiol Biotechnol; 2010 Feb; 85(5):1551-63. PubMed ID: 19756586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
    Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
    J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin induces drug efflux pumps in Candida albicans.
    Kofla G; Turner V; Schulz B; Storch U; Froelich D; Rognon B; Coste AT; Sanglard D; Ruhnke M
    Med Mycol; 2011 Feb; 49(2):132-42. PubMed ID: 20818920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
    MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
    Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
    Hirasawa M; Takada K
    J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesol-mediated inhibition of Candida albicans yeast growth and rescue by a diacylglycerol analogue.
    Uppuluri P; Mekala S; Chaffin WL
    Yeast; 2007 Aug; 24(8):681-93. PubMed ID: 17583896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-amino-nonyl-6-methoxyl-tetralin muriate activity against Candida albicans augments endogenous reactive oxygen species production --a microarray analysis study.
    Liang RM; Yong XL; Jiang YP; Tan YH; Dai BD; Wang SH; Hu TT; Chen X; Li N; Dong ZH; Huang XC; Chen J; Cao YB; Jiang YY
    FEBS J; 2011 Apr; 278(7):1075-85. PubMed ID: 21251230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of diclofenac sodium in the dimorphic transition in Candida albicans.
    Ghalehnoo ZR; Rashki A; Najimi M; Dominguez A
    Microb Pathog; 2010; 48(3-4):110-5. PubMed ID: 20026399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of polyene antibiotics on protein synthesis by free and membrane-bound ribosomes of Candida albicans].
    Lishnevskaia EB; Belousova II; Rodygina TN; Tereshin IM
    Biokhimiia; 1976; 41(7):1169-75. PubMed ID: 793640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.